EP3125897A4 - Composés bicycliques de cyclopentapyrimidine substitués ayant une activité antimitotique et/ou antitumorale et leurs méthodes d'utilisation - Google Patents

Composés bicycliques de cyclopentapyrimidine substitués ayant une activité antimitotique et/ou antitumorale et leurs méthodes d'utilisation Download PDF

Info

Publication number
EP3125897A4
EP3125897A4 EP15779898.4A EP15779898A EP3125897A4 EP 3125897 A4 EP3125897 A4 EP 3125897A4 EP 15779898 A EP15779898 A EP 15779898A EP 3125897 A4 EP3125897 A4 EP 3125897A4
Authority
EP
European Patent Office
Prior art keywords
antimitotic
methods
antitumor activity
bicyclic compounds
substituted cyclopenta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15779898.4A
Other languages
German (de)
English (en)
Other versions
EP3125897A2 (fr
Inventor
Aleem Gangjee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duquesne University of the Holy Spirit
Original Assignee
Duquesne University of the Holy Spirit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/244,445 external-priority patent/US9624178B2/en
Application filed by Duquesne University of the Holy Spirit filed Critical Duquesne University of the Holy Spirit
Publication of EP3125897A2 publication Critical patent/EP3125897A2/fr
Publication of EP3125897A4 publication Critical patent/EP3125897A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP15779898.4A 2014-04-03 2015-03-27 Composés bicycliques de cyclopentapyrimidine substitués ayant une activité antimitotique et/ou antitumorale et leurs méthodes d'utilisation Withdrawn EP3125897A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/244,445 US9624178B2 (en) 2008-07-10 2014-04-03 Substituted cyclopenta pyrimidine bicyclic compounds having antitmitotic and/or antitumor activity methods of use thereof
PCT/US2015/022871 WO2015160489A2 (fr) 2014-04-03 2015-03-27 Composés bicycliques de cyclopentapyrimidine substitués ayant une activité antimitotique et/ou antitumorale et leurs méthodes d'utilisation

Publications (2)

Publication Number Publication Date
EP3125897A2 EP3125897A2 (fr) 2017-02-08
EP3125897A4 true EP3125897A4 (fr) 2017-11-15

Family

ID=54324696

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15779898.4A Withdrawn EP3125897A4 (fr) 2014-04-03 2015-03-27 Composés bicycliques de cyclopentapyrimidine substitués ayant une activité antimitotique et/ou antitumorale et leurs méthodes d'utilisation

Country Status (4)

Country Link
EP (1) EP3125897A4 (fr)
JP (1) JP6532887B2 (fr)
CA (1) CA2944450C (fr)
WO (1) WO2015160489A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0067630A1 (fr) * 1981-06-05 1982-12-22 Sankyo Company Limited Dérivés de pyrimidine, procédé pour leur préparation et compositions pharmaceutiques les contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US8946239B2 (en) 2008-07-10 2015-02-03 Duquesne University Of The Holy Spirit Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
AU2010339444A1 (en) 2009-12-30 2012-07-19 Arqule, Inc. Substituted pyrrolo-aminopyrimidine compounds
US9139590B2 (en) * 2011-02-04 2015-09-22 Duquesne University Of The Holy Spirit Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0067630A1 (fr) * 1981-06-05 1982-12-22 Sankyo Company Limited Dérivés de pyrimidine, procédé pour leur préparation et compositions pharmaceutiques les contenant

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ALEEM GANGJEE ET AL: "Structure-Activity Relationship and in Vitro and in Vivo Evaluation of the Potent Cytotoxic Anti-microtubule Agent N -(4-Methoxyphenyl)- N ,2,6-trimethyl-6,7-dihydro-5 H -cyclopenta[ d ]pyrimidin-4-aminium Chloride and Its Analogues As Antitumor Agents", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, no. 17, 12 September 2013 (2013-09-12), US, pages 6829 - 6844, XP055675876, ISSN: 0022-2623, DOI: 10.1021/jm400639z *
ALEEM GANGJEE ET AL: "Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance", JOURNAL OF MEDICINAL CHEMISTRY, vol. 53, no. 22, 25 November 2010 (2010-11-25), pages 8116 - 8128, XP055120721, ISSN: 0022-2623, DOI: 10.1021/jm101010n *
CHENXIAO DA ET AL: "How to Deal with Low-Resolution Target Structures: Using SAR, Ensemble Docking, Hydropathic Analysis, and 3D-QSAR to Definitively Map the [alpha][beta]-Tubulin Colchicine Site", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, no. 18, 26 September 2013 (2013-09-26), US, pages 7382 - 7395, XP055675899, ISSN: 0022-2623, DOI: 10.1021/jm400954h *
DAO-LIN WANG ET AL: "New Synthetic Approach to 4- N -Arylaminoazuleno[2,1- d ]pyrimides", SYNTHETIC COMMUNICATIONS, vol. 39, no. 13, 9 June 2009 (2009-06-09), PHILADELPHIA, PA; US, pages 2329 - 2338, XP055413566, ISSN: 0039-7911, DOI: 10.1080/00397910802654807 *
See also references of WO2015160489A2 *

Also Published As

Publication number Publication date
WO2015160489A2 (fr) 2015-10-22
JP6532887B2 (ja) 2019-06-19
CA2944450C (fr) 2023-03-21
CA2944450A1 (fr) 2015-10-22
JP2017512805A (ja) 2017-05-25
EP3125897A2 (fr) 2017-02-08
WO2015160489A3 (fr) 2016-03-31

Similar Documents

Publication Publication Date Title
IL276690A (en) Neural microphysiological systems and methods for their use
EP3210200A4 (fr) Procédés d'amélioration de la cognition et systèmes permettant de pratiquer ceux-ci
EP3510138A4 (fr) Systèmes distribués pour la production et l'utilisation efficaces de compositions à base de microbes
EP3377070A4 (fr) Composés et leurs méthodes d'utilisation
EP3218005A4 (fr) Composés interagissant avec le glycane et procédés d'utilisation
EP3207614A4 (fr) Systèmes capables d'auto-collecter de l'énergie à partir de dispositifs sans fil et leurs procédés d'utilisation
EP3313529A4 (fr) Dérivés de pyrimidine bicycliques fusionnés et leurs utilisations
EP3096835A4 (fr) Systèmes et procédés associés pour optimiser une stimulation de nerf à multiples électrodes
EP3380577A4 (fr) Particules revêtues et leurs procédés de production et d'utilisation
EP3166593A4 (fr) Compositions antivirales topiques et méthodes d'utilisation de celles-ci
EP3107904A4 (fr) Delta-lactones substituées et leurs procédés de préparation
EP3455322A4 (fr) Hydrofluorooléfines et leurs procédés d'utilisation
EP3151943B8 (fr) Panneau filtrant et son procédé de fabrication
EP3221461A4 (fr) Microbes produisant des noscapinoïdes et leurs méthodes de production et d'utilisation
EP3096892A4 (fr) Substrats revêtus de nanotubes de carbone et leurs procédés de fabrication
EP3194421A4 (fr) Composés cytotoxiques et antimitotiques et leurs procédés d'utilisation
EP3099493A4 (fr) Barres d'impression et procédés de formation de barres d'impression
EP3166630A4 (fr) Vaccins dirigés contre une isoforme oncogène d'esr1 et leurs méthodes d'utilisation
EP3119796A4 (fr) Synthèse de nucléosides bicycliques
IL287119A (en) Bryostatin compounds and methods for their preparation
EP3193754A4 (fr) Systèmes de fusion à niveau unique et procédés d'assemblage et d'utilisation
EP3193755A4 (fr) Systèmes de fusion et procédés d'assemblage et d'utilisation associés
EP3141601A4 (fr) Dicarbonylé réductase mutant et son application
EP3204121A4 (fr) Promédicaments sous forme de pyrimidine silylée et méthodes d'utilisation desdits promédicaments
EP3154547A4 (fr) Composés pyrimidiques et procédés les utilisant

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20161102

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20171017

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 239/70 20060101ALI20171011BHEP

Ipc: A61K 31/517 20060101AFI20171011BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180817

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031517000

Ipc: C07D0239700000

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20220805BHEP

Ipc: A61K 31/517 20060101ALI20220805BHEP

Ipc: C07D 491/048 20060101ALI20220805BHEP

Ipc: C07D 487/04 20060101ALI20220805BHEP

Ipc: C07D 239/70 20060101AFI20220805BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20220916

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230127